...
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in the Serum of Patients with Non-alcoholic Fatty Liver Disease
【24h】

Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in the Serum of Patients with Non-alcoholic Fatty Liver Disease

机译:非酒精性脂肪肝病患者血清中醇脱氢酶同工酶和醛脱氢酶活性

获取原文
获取原文并翻译 | 示例

摘要

Background/Aim: Non-alcoholic liver disease (NAFLD) is one of the most common causes of chronic liver disease, and its prevalence and medical importance is increasing worldwide. Changes in enzyme activity in liver cells in various liver diseases are reflected by an increase in serum enzymatic activity. For example, alcohol dehydrogenase activity (ADH) and aldehyde dehydrogenase (ALDH), that occur in the liver in large quantities, correlate with disease severity during cirrhosis. In the current study, the activity of ADH isoenzymes and ALDH in the serum of patients with NAFLD was investigated. Materials and Methods: Serum samples were collected for routine biochemical studies from 55 patients with NAFLD patients and from 50 healthy individuals. Class I and II ADH and ALDH activity were measured by spectrofluorometric method. Photometric methods were used to measure ADH class III, IV and total ADH activity. Results: Total ADH activity was significantly higher in non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) than in healthy individuals (44 and 48.5% activity, respectively). The median total activity of ADH was 1,164 mU/l in patients with NAFLD, 1,258 mU/l in NASH and 648 mU/l in the control group. The increase in ADH class I and II isoenzyme in serum of patients with NAFL and NASH was statistically significant. The activity of ADH I, ADH II, and total ADH significantly increased with increasing disease progression. Conclusion: The activity of isozymes of class I and II alcohol dehydrogenase in patients with NAFLD is enhanced and appears to be due to the release of these isoenzymes from damaged hepatocytes.
机译:背景/目的:非酒精性肝病(NAFLD)是慢性肝病最常见的原因之一,其流行和医学重要性在全世界增加。各种肝脏疾病中肝细胞中酶活性的变化被血清酶活性的增加反映。例如,醇脱氢酶活性(ADH)和醛脱氢酶(ALDH),其在肝脏中发生的大量发生,肝硬化期间的疾病严重程度相关。在目前的研究中,研究了NAFLD患者血清中ADH同胞酶和ALDH的活性。材料和方法:收集血清样品,用于从55例NAFLD患者和50名健康个体患者进行常规生物化学研究。通过光谱荧光法测量I和II ADH和ALDH活性。光度法用于测量ADH类III,IV和总ADH活性。结果:非酒精性脂肪肝(NAFL)和非酒精脂肪疏皮性(NASH)的总ADH活性显着高于健康个体(分别为44和48.5%)。 ADH中位数的总活性为NASHLD,NASH的1,258亩/ L患者1,164亩/ L.对照组中的648亩/ L. NAFL和NASH患者血清中ADH类I和II同工酶的增加在统计学上显着。随着疾病进展的增加,ADH I,ADH II和总ADH的活性显着增加。结论:提高NAFLD患者I类和II醇脱氢酶的同工酶活性,似乎是由于这些同工酶免受肝细胞的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号